Literature DB >> 10086339

The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated.

F Bolognese1, M Wasner, C L Dohna, A Gurtner, A Ronchi, H Muller, I Manni, J Mossner, G Piaggio, R Mantovani, K Engeland.   

Abstract

Cyclin B2 is a regulator of p34cdc2 kinase, involved in G2/M progression of the cell cycle, whose gene is strictly regulated at the transcriptional level in cycling cells. The mouse promoter was cloned and three conserved CCAAT boxes were found. In this study, we analysed the mechanisms leading to activation of the cyclin B2 CCAAT boxes: a combination of (i) genomic footprinting, (ii) transfections with single, double and triple mutants, (iii) EMSAs with nuclear extracts, antibodies and NF-Y recombinant proteins and (iv) transfections with an NF-YA dominant negative mutant established the positive role of the three CCAAT sequences and proved that NF-Y plays a crucial role in their activation. NF-Y, an ubiquitous trimer containing histone fold subunits, activates several other promoters regulated during the cell cycle. To analyse the levels of NF-Y subunits in the different phases of the cycle, we separated MEL cells by elutriation, obtaining fractions >80% pure. The mRNA and protein levels of the histone-fold containing NF-YB and NF-YC were invariant, whereas the NF-YA protein, but not its mRNA, was maximal in mid-S and decreased in G2/M. EMSA confirmed that the CCAAT-binding activity followed the amount of NF-YA, indicating that this subunit is limiting within the NF-Y complex, and suggesting that post-transcriptional mechanisms regulate NF-YA levels. Our results support a model whereby fine tuning of this activator is important for phase-specific transcription of CCAAT-containing promoters.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086339     DOI: 10.1038/sj.onc.1202494

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743.

Authors:  M Minuzzo; S Marchini; M Broggini; G Faircloth; M D'Incalci; R Mantovani
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  The tumour suppressor protein p53 can repress transcription of cyclin B.

Authors:  K Krause; M Wasner; W Reinhard; U Haugwitz; C L Dohna; J Mössner; K Engeland
Journal:  Nucleic Acids Res       Date:  2000-11-15       Impact factor: 16.971

3.  A single cell cycle genes homology region (CHR) controls cell cycle-dependent transcription of the cdc25C phosphatase gene and is able to cooperate with E2F or Sp1/3 sites.

Authors:  Ulrike Haugwitz; Mark Wasner; Marcus Wiedmann; Katja Spiesbach; Karen Rother; Joachim Mössner; Kurt Engeland
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

4.  Characterization of the human ephrin-A4 promoter.

Authors:  Else Munthe; Hans-Christian Aasheim
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

5.  Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation.

Authors:  Aymone Gurtner; Isabella Manni; Paola Fuschi; Roberto Mantovani; Fiorella Guadagni; Ada Sacchi; Giulia Piaggio
Journal:  Mol Biol Cell       Date:  2003-04-04       Impact factor: 4.138

6.  NF-Y is necessary for hematopoietic stem cell proliferation and survival.

Authors:  Gerd Bungartz; Hannah Land; David T Scadden; Stephen G Emerson
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

7.  The CCAAT/enhancer binding protein beta is a critical regulator of steroid-induced mitotic expansion of uterine stromal cells during decidualization.

Authors:  Wei Wang; Quanxi Li; Indrani C Bagchi; Milan K Bagchi
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

8.  Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.

Authors:  Carol Imbriano; Aymone Gurtner; Fabienne Cocchiarella; Silvia Di Agostino; Valentina Basile; Monica Gostissa; Matthias Dobbelstein; Giannino Del Sal; Giulia Piaggio; Roberto Mantovani
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

9.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

10.  Discovering functional transcription-factor combinations in the human cell cycle.

Authors:  Zhou Zhu; Jay Shendure; George M Church
Journal:  Genome Res       Date:  2005-06       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.